As they reported, AAv-mediated RPGRIP gene replacement preserves photoreceptor structure and function in LCA mouse models, which showed gene replacement therapy may be effective in patients with LCA due to defects in RPGRIP and suggests the need for further preclinical development of gene therapy for this disease. Here, RPGRIP1 is linked to Leber congenital amaurosis.